Advanced search
1 file | 25.10 KB Add to list

Long non-coding RNAs as novel components in the TP53 pathway

Author
Organization

Downloads

  • 2016 02 12 Oncopoint DRM.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 25.10 KB

Citation

Please use this url to cite or link to this publication:

MLA
Rombaut, Dries, Steve Lefever, Jan Koster, et al. “Long Non-coding RNAs as Novel Components in the TP53 Pathway.” OncoPoint, 4th Research Seminar, Abstracts. 2016. Print.
APA
Rombaut, D., Lefever, S., Koster, J., Schulte, J., Versteeg, R., van Sluis, P., Vandesompele, J., et al. (2016). Long non-coding RNAs as novel components in the TP53 pathway. OncoPoint, 4th Research seminar, Abstracts. Presented at the 4th OncoPoint research seminar.
Chicago author-date
Rombaut, Dries, Steve Lefever, Jan Koster, Johannes Schulte, Rogier Versteeg, Peter van Sluis, Jo Vandesompele, and Pieter Mestdagh. 2016. “Long Non-coding RNAs as Novel Components in the TP53 Pathway.” In OncoPoint, 4th Research Seminar, Abstracts.
Chicago author-date (all authors)
Rombaut, Dries, Steve Lefever, Jan Koster, Johannes Schulte, Rogier Versteeg, Peter van Sluis, Jo Vandesompele, and Pieter Mestdagh. 2016. “Long Non-coding RNAs as Novel Components in the TP53 Pathway.” In OncoPoint, 4th Research Seminar, Abstracts.
Vancouver
1.
Rombaut D, Lefever S, Koster J, Schulte J, Versteeg R, van Sluis P, et al. Long non-coding RNAs as novel components in the TP53 pathway. OncoPoint, 4th Research seminar, Abstracts. 2016.
IEEE
[1]
D. Rombaut et al., “Long non-coding RNAs as novel components in the TP53 pathway,” in OncoPoint, 4th Research seminar, Abstracts, Ghent, Belgium, 2016.
@inproceedings{8509911,
  author       = {Rombaut, Dries and Lefever, Steve and Koster, Jan and Schulte, Johannes and Versteeg, Rogier and van Sluis, Peter and Vandesompele, Jo and Mestdagh, Pieter},
  booktitle    = {OncoPoint, 4th Research seminar, Abstracts},
  language     = {eng},
  location     = {Ghent, Belgium},
  title        = {Long non-coding RNAs as novel components in the TP53 pathway},
  year         = {2016},
}